ENGNW
enGene Holdings Inc. Warrants
NASDAQ · Healthcare · Biotechnology · CA
$0.21
−4.55%Leverage
- Debt / equity
- 0.13x
- Net debt / equity
- 0.01x
- Debt / assets
- 0.11x
- Debt / EBITDA
- -0.26x
- Net debt / EBITDA
- -0.03x
Liquidity & coverage
- Current ratio
- 12.57x
- Quick ratio
- 12.57x
- Cash ratio
- 12.03x
- Interest coverage
- -23.00x
- EBITDA / interest
- -42.19x
- Working capital
- $248.5M
Cash & dividend
- FCF / debt
- -3.34x
- Cash flow / debt
- -3.30x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Apr 1, 2026